PT1024815E - Composicoes farmaceuticas para administracao oral de iodo molecular - Google Patents

Composicoes farmaceuticas para administracao oral de iodo molecular

Info

Publication number
PT1024815E
PT1024815E PT98954002T PT98954002T PT1024815E PT 1024815 E PT1024815 E PT 1024815E PT 98954002 T PT98954002 T PT 98954002T PT 98954002 T PT98954002 T PT 98954002T PT 1024815 E PT1024815 E PT 1024815E
Authority
PT
Portugal
Prior art keywords
iodine
mammal
molecular iodine
molecular
pharmaceutical compositions
Prior art date
Application number
PT98954002T
Other languages
English (en)
Inventor
Yongjun Duan
John Hickey
Rick Panicucci
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of PT1024815E publication Critical patent/PT1024815E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98954002T 1997-10-29 1998-10-27 Composicoes farmaceuticas para administracao oral de iodo molecular PT1024815E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine

Publications (1)

Publication Number Publication Date
PT1024815E true PT1024815E (pt) 2003-06-30

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98954002T PT1024815E (pt) 1997-10-29 1998-10-27 Composicoes farmaceuticas para administracao oral de iodo molecular

Country Status (17)

Country Link
US (1) US5885592A (pt)
EP (1) EP1024815B1 (pt)
JP (1) JP4187410B2 (pt)
KR (1) KR100412219B1 (pt)
CN (1) CN1150904C (pt)
AT (1) ATE231725T1 (pt)
AU (1) AU750627B2 (pt)
BR (1) BR9812588A (pt)
CA (1) CA2301503C (pt)
DE (1) DE69811105T2 (pt)
DK (1) DK1024815T3 (pt)
ES (1) ES2191973T3 (pt)
IL (1) IL134778A0 (pt)
NO (1) NO20001673L (pt)
PT (1) PT1024815E (pt)
RU (1) RU2213564C2 (pt)
WO (1) WO1999021567A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
WO1999034809A1 (fr) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Preparations solides a base d'iodophore et procede de fabrication correspondant
DE69910210T2 (de) 1998-06-19 2004-06-17 Oxibio, Inc., Portland Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
ES2359818T3 (es) * 2003-06-20 2011-05-27 Hill's Pet Nutrition, Inc. Métodos para hipertiroidismo en un gato y composición que comprende yodo limitado.
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
CA2823751C (en) * 2006-01-26 2015-10-06 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism
CA2650845C (en) * 2006-05-12 2015-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CA2656608C (en) * 2006-07-03 2014-09-16 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
EP2606885B1 (en) * 2011-05-16 2016-05-11 Begaliev, Shokan Sabirkhanovich Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
JP6573620B2 (ja) * 2014-02-10 2019-09-11 フレッド ハッチンソン キャンサー リサーチ センター 心臓発作及び虚血損傷のハロゲン治療
WO2015153258A1 (en) 2014-03-31 2015-10-08 Iotech International, Llc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
KR20190123716A (ko) 2016-07-21 2019-11-01 아이오젠, 엘엘씨 연화성 국소 소독제
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
TW202203900A (zh) * 2020-03-31 2022-02-01 越南商泰明製藥股份有限公司 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
RU2213564C2 (ru) 2003-10-10
ATE231725T1 (de) 2003-02-15
BR9812588A (pt) 2000-07-25
WO1999021567A1 (en) 1999-05-06
IL134778A0 (en) 2001-04-30
CN1272789A (zh) 2000-11-08
US5885592A (en) 1999-03-23
CA2301503A1 (en) 1999-05-06
ES2191973T3 (es) 2003-09-16
JP4187410B2 (ja) 2008-11-26
EP1024815B1 (en) 2003-01-29
DE69811105D1 (de) 2003-03-06
AU750627B2 (en) 2002-07-25
DE69811105T2 (de) 2003-11-06
CA2301503C (en) 2005-01-04
NO20001673D0 (no) 2000-03-31
NO20001673L (no) 2000-05-24
AU1122799A (en) 1999-05-17
CN1150904C (zh) 2004-05-26
JP2003510243A (ja) 2003-03-18
EP1024815A1 (en) 2000-08-09
KR20010030861A (ko) 2001-04-16
DK1024815T3 (da) 2003-05-19
KR100412219B1 (ko) 2003-12-24

Similar Documents

Publication Publication Date Title
PT1024815E (pt) Composicoes farmaceuticas para administracao oral de iodo molecular
EP0699072A4 (en) IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION
HK1077501A1 (en) Improved delivery of multiple doses of a methylphenidate drug
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
MXPA02010322A (es) Metodos para la prevencion y tratamiento de trastornos gastrointestinales.
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
ATE394107T1 (de) Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP1064950A4 (en) NEW REMEDIES AGAINST HEPATITIS
EP0805684A4 (en) METHODS OF IMPROVING THE THERAPEUTIC ACTIVITY OF NON-STEROID ANTI-INFLAMMATORY DRUGS (NSAIDS) AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREFOR
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
EP0271151A3 (en) Azumolene dosage form
EP0835662A3 (en) A drug for the treatment of cancer
SE8701077D0 (sv) Pharmaceutical composition
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand
ATE240097T1 (de) Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten
OSBORNE The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
RU97110400A (ru) Способ профилактики и лечения больных, страдающих эстрогенно- и андрогенозависимыми опухолями
RU94013463A (ru) Способ и композиция для лечения заболеваний желудка и двенадцатиперстной кишки и новые производные пге2
UA10335A (uk) Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології